CompuGroup Medical SE/ DE000A288904 /
2024-07-05 3:46:08 PM | Chg. - | Volume | Bid9:00:15 AM | Ask9:00:15 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
23.82EUR | - | 139 Turnover: 3,310.98 |
-Bid Size: - | -Ask Size: - | 721.89 mill.EUR | 7.24% | 15.70 |
Assets
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 73.9000 | 82.8000 | 83.7000 | 88.1000 | 91.8000 | ||||||
Intangible Assets | 538.2000 | 534.6000 | 536.5000 | 668.3000 | 1,088.1000 | ||||||
Long-Term Investments | 5.6000 | 12.4000 | 12 | 11.4000 | 12.9000 | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | 5.3000 | 12.5000 | 19.6000 | 27.5000 | 18.2000 | ||||||
Accounts Receivable | 116.8000 | 116.1000 | 111.4000 | 103 | 137.2000 | ||||||
Cash and Cash Equivalents | 27.8000 | 30.4000 | 25.3000 | 46.4000 | 75.9000 | ||||||
Current Assets | 169.2000 | 178 | 191.8000 | 232.9000 | 308.1000 | ||||||
Total Assets | 807.9000 | 825 | 848.3000 | 1,065.9000 | 1,565.8000 |
Liabilities
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 31.4000 | 43.9000 | 39.3000 | 47.1000 | 64.5000 | ||||||
Long-term debt | 328.6000 | 327.1000 | 319.7000 | 424.5000 | 470.2000 | ||||||
Liabilities to Banks | 382.1000 | 370.4000 | 337.1000 | 471.2000 | 515.3000 | ||||||
Provisions | 95.4000 | 97.5000 | 100 | 130.8000 | 149.5000 | ||||||
Liabilities | 589.3000 | 589 | 575.3000 | 805.9000 | 926.8000 | ||||||
Share Capital | 53.2190 | 53.2190 | 53.2190 | 53.2190 | 53.7350 | ||||||
Total Equity | 218.7000 | 236.1000 | 273 | 259.9000 | 638.9000 | ||||||
Minority Interests | .8000 | 1.9000 | 2.1000 | .8000 | .3000 | ||||||
Total liabilities equity | 807.9000 | 825 | 848.3000 | 1,065.9000 | 1,565.8000 |
Income Statement
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 560.2000 | 582.4000 | 717 | 745.8000 | 837.3000 | ||||||
Depreciation (total) | 43.8000 | 38.3000 | 44.6000 | 62.9000 | 75.5000 | ||||||
Operating Result | 81.8000 | 90.1000 | 137.9000 | 115.3000 | 121.8000 | ||||||
Interest Income | -6.2000 | -23.3000 | -8.8000 | -5.7000 | -10.4000 | ||||||
Income Before Taxes | 74.2000 | 65.6000 | 128.8000 | 107.7000 | 110.4000 | ||||||
Income Taxes | 29.7000 | 33.8000 | 36.2000 | 41.6000 | 37 | ||||||
Minority Interests Profit | .0600 | -.4000 | -.3000 | -.3000 | -.2000 | ||||||
Net Income | 44.5000 | 31.3000 | 92.3000 | 65.8000 | 73.2000 |
Per Share
Cash Flow
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 67.6000 | 85.8000 | 136.3000 | 110.5000 | 149.9000 | ||||||
Cash Flow from Investing Activities | -49.4000 | -54.9000 | -47.5000 | -139.4000 | -457.1000 | ||||||
Cash Flow from Financing | -15.7000 | -28 | -93.4000 | 49.7000 | 338.1000 | ||||||
Decrease / Increase in Cash | 2.5000 | 2.9000 | -4.5000 | 20.7000 | 30.9000 | ||||||
Employees | 4,332 | 4,572 | 4,955 | 5,627 | 7,814 |